Tile Shop Holdings, Inc. (NASDAQ:TTS) is gaining traction with investors, as evidenced by its 0.68 million shares volume. The daily trading volume average remained 1.14 million shares over the course of 3 months. The stock had opened the regular trading at $8.35 and managed a 4.19% price change to reach $8.7 through the close.Tile Shop Holdings, Inc. (TTS) Analyst Opinion
Tile Shop Holdings, Inc. has a consensus hold rating from 7 Wall Street analysts, and the number of shares currently sold short amount to at least 5.99% of shares outstanding. The stock sank -7.94% last month and is down -55.5 this year. Wall Street is only getting more bearish on the stock, with 0 of analysts who cover TTS having a buy-equivalent rating. Analysts have placed a $8.79 price target on Tile Shop Holdings, Inc., suggesting a 1.03% gain from recent close. It’s currently trading about -61.16% below its 52-week high.
Tile Shop Holdings, Inc. (TTS) failed to surprise the stock market in its last reported earnings when it earned $0.05 a piece versus the consensus-estimated $0.05. Its revenue totaled $84.05 million down -6.05% from the previous quarter.Tile Shop Holdings, Inc. (NASDAQ:TTS) Intraday View
This stock (TTS) is ahead of its 52-week low with 7.68%. Its last month’s stock price volatility remained 4.2% which for the week stands at 4.39%. The share price has moved forward from its 20 days moving average, trading at a distance of 1.25% and stays -16.01% away from its 50 days moving average. Over the last five days, shares have managed 3.57% gains and now is down -46.95% since hitting its 200-day moving average of $15.2. Tile Shop Holdings, Inc. (TTS) has made its way to a 12-month decline of -55.84%.
Turning to Vitamin Shoppe, Inc. (NYSE:VSI), its shares were trading at $3.9 a retreat of $-0.2, on the trading floor. The stock, after opening at $4.1, touched a high of $4.15 before paring much of its gains. So far, analysts are sticking with their bearish recommendations with the consensus call at 3. Vitamin Shoppe, Inc. has 0 buy ratings, 6 holds and 0 sells even after the stock tumbled -85.2% from its high of $26.35 to a $85.72 million market value through last close.
The company’s consensus rating on Reuter’s scale slipped from 3.25 to 3.14 during a month. Analysts set a 12-month price target of $4 a share. The target implies a 2.56% spike from where the shares are currently trading. Also, the current price highlights a discount of 53.85% to analysts’ high consensus price target.Vitamin Shoppe, Inc. (NYSE:VSI) Intraday Trading
The counter witnessed a trading volume of 0.58 million shares versus an average volume of 0.66 million shares during last trading session. Its last month’s stock price volatility remained 9.08% which for the week approaches 7.93%. The lowest price the stock reached in the last trading day was $3.8 and compares with the $2.95 52-week low. The stock recovered 32.2% since its low point and has performed -83.58% year-to-date.